Funding for this research was provided by:
National Natural Science Foundation of China (81201700)
Innovation Promotion Association CAS (2016098)
Major State Basic Research Development Program (2014CB542006)
the Key Research Program of the Chinese Academy of Sciences (KJZD-EW-L14)
National Science and Technology Support Program (2012BAI11B05)
Capital's Funds for Health Improvement and Research (2018-1-1151)
Received: 26 February 2020
Accepted: 12 June 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of Beijing You’an Hospital and Beijing Institute of Genomics (IRB number 2016H005). An informed written consent was obtained from all patients and volunteers.
: Not applicable.
: The authors declare that they have no competing interests.